16 - 30 of 156 Items

Review article2022, oct 5

Autoimmune cytopenias in chronic lymphocytic leukemia: a growing challenge in targeted therapies?

Jagoda Tryc-Szponder, Monika Joks, Lidia Gil

Vol 53, No 5 (2022)

Review article

Acta Haematol Pol 2022;53(5):316-325.
Clinical vignette2022, aug 4

Double transformation of relapsing juvenile myelomonocytic leukemia to refractory acute myeloid leukemia

Tomasz Styczyński, Jagoda Sadlok, Monika Richert-Przygońska, Robert Dębski, Małgorzata Kubicka, Beata Kuryło-Rafińska, Krzysztof Czyżewski

Vol 53, No 4 (2022)

Clinical vignette

Acta Haematol Pol 2022;53(4):295-297.
Original research article2022, jun 5

Treosulfan-based conditioning vs. low-dose busulfan-based conditioning for allogeneic hematopoietic stem cell transplantation: a cost-utility analysis in Poland

Paweł Kawalec, Przemysław Holko, George Bungey, Owen Moseley, Magdalena Żegleń, Mirosław Markiewicz

Vol 53, No 3 (2022)

Original research article

Acta Haematol Pol 2022;53(3):191-200.
Original research article2022, jun 6

Survival in patients with multiple myeloma: a real-life single-center study

Marek Rodzaj, Anna Morawska-Krekora, Malgorzata Razny, Beata Jakubas

Vol 53, No 3 (2022)

Original research article

Acta Haematol Pol 2022;53(3):201-206.
Clinical vignette2023, apr 7

Tisagenlecleucel CAR-T for relapsed/refractory diffuse large B-cell lymphoma, one therapy; two different clinical presentations. An urgent need to design adverse event predictors

Jaromir Tomasik, Joanna Drozd-Sokołowska, Piotr Kacprzyk, Agnieszka Tomaszewska, Rafał Machowicz, Elżbieta Urbanowska, Samanta Witkowska, Grzegorz Władysław Basak

Vol 54, No 2 (2023)

Clinical vignette

Acta Haematol Pol 2023;54(2):100-103.
Editorial2022, apr 29

Incidence and disease prevalence for lymphoid neoplasms in Poland

Krzysztof Giannopoulos

Vol 53, No 2 (2022)

Editorial

Acta Haematol Pol 2022;53(2):73-74.
Review article2022, apr 5

Chronic myeloid leukemia: where do we stand, where can we go?

Krzysztof Lewandowski, Jakub Lewandowski

Vol 53, No 3 (2022)

Review article

Acta Haematol Pol 2022;53(3):153-165.
Review article2022, may 23

CAR-T therapy in mantle cell lymphoma: a review of the current literature

Joanna Romejko-Jarosińska

Vol 53, No 3 (2022)

Review article

Acta Haematol Pol 2022;53(3):166-175.
Clinical vignette2022, jun 10

Primary refractory primary mediastinal lymphoma treated with CAR-T: new possibilities and challenges

Krzysztof Żyłka, Dominik Dytfeld, Lidia Gil

Vol 53, No 3 (2022)

Clinical vignette

Acta Haematol Pol 2022;53(3):215-217.
Original research article2022, nov 14
Original research article2023, may 24

Use of Mindray MC-80 digital morphology analyzer’s estimated platelet counts as adjunct to automated hematology analyzer

Yasemin Üstündağ, Kağan Huysal, Elif Güler Kazancı, Fatih Yıldırım, Meryem Rümeysa Yeşil

Vol 54, No 3 (2023)

Original research article

Acta Haematol Pol 2023;54(3):169-175.
Review article2022, nov 22

Influence of gut microbiota on efficacy and adverse effects of treatment of lymphoproliferative disorders

Klaudia Zielonka, Marcin Jasiński, Krzysztof Jamroziak

Vol 53, No 6 (2022)

Review article

Acta Haematol Pol 2022;53(6):363-375.
Original research article2023, may 7
Original research article2023, apr 4

Effect of iron deficiency anemia on blood levels of interleukin 6 and infection rates in children: a pilot study

Agata Kolasa, Gabriela Ręka, Zuzanna Radziejowska, Alicja Bielak, Mariola Janiszewska, Katarzyna Drabko

Vol 54, No 2 (2023)

Original research article

Acta Haematol Pol 2023;54(2):93-99.
Review article2022, jul 28

A living drug: application of CAR-T therapy for lymphoid malignancies and beyond

Anna Strzelec, Anna Klima, Natalia Gawlik-Rzemieniewska, Grzegorz Helbig

Vol 53, No 4 (2022)

Review article

Acta Haematol Pol 2022;53(4):241-248.